Trials / Completed
CompletedNCT06000683
Empowering Patients' Lung Cancer Screening Uptake
Empowering Patients' Lung Cancer Screening Uptake (Empower LCS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- University of California, Irvine · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Patient education | Patients will be sent information (in preferred language) on lung cancer risk, lung cancer screening (LCS) benefits, harms, false positive rates, recommendations of follow-up for positive results, and exam insurance coverage. |
| BEHAVIORAL | Referral to financial navigation resources | Patients who self-report needing help with health-related social risks at baseline will be sent a brochure (in preferred language) from patient advocate foundation (PAF), a national non-profit financial navigation organization, where patients can self-refer. |
| BEHAVIORAL | Patient Reminders | Within 2 weeks prior to primary care appointment, patients will receive a text message or a phone call (if not having a phone that receives text messaging) encouraging patients to discuss the LCS with their provider. |
| BEHAVIORAL | Provider Reminers | Within 2 weeks prior to primary care appointment, providers will be notified of their patient's eligibility for LCS. |
Timeline
- Start date
- 2023-10-13
- Primary completion
- 2025-03-21
- Completion
- 2025-11-25
- First posted
- 2023-08-21
- Last updated
- 2026-02-20
- Results posted
- 2026-02-03
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06000683. Inclusion in this directory is not an endorsement.